Condition
Pancreatitis Relapsing
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
P 3 (1)
P 4 (1)
Trial Status
Not Yet Recruiting1
Unknown1
Terminated1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07617155Phase 4Not Yet Recruiting
GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis
NCT04021498Phase 3TerminatedPrimary
Simvastatin in the Prevention of Recurrent Pancreatitis
NCT06124989Unknown
Machine learnINg for the rElapse Risk eValuation in Acute Biliary Pancreatitis.
Showing all 3 trials